Boston Scientific (NYSE:BSX) said yesterday that it has resolved its patent infringement litigation against Micro-Tech Endoscopy over hemostasis clips used in endoscopy procedures.
The clips are applied to tissue or blood vessels to stop gastrointestinal bleeding.
Get the full story on our sister site, Medical Design & Outsourcing.
Micro-Tech’s SureClip
Boston Scientific (NYSE:BSX) said yesterday that it has resolved its patent infringement litigation against Micro-Tech Endoscopy over hemostasis clips used in endoscopy procedures.
Boston Scientific said it will grant a five-year, royalty-bearing license to Ann-Arbor, Mich.-based Micro-Tech for the patented hemostasis clip technology. The clips are applied to tissue or blood vessels to stop gastrointestinal bleeding.
In exchange, Micro-Tech agreed to drop its patent validity challenges, Marlborough, Massachusetts-based Boston Scientific said.
“The settlement resolves all worldwide litigation between the companies,” Boston Scientific said in a news release.
Boston Scientific sued not only Micro-Tech, but also Chinese manufacturer Micro-Tech Nanjing and distributor Henry Schein. Boston Scientific’s lawsuit — filed in U.S. District Court in Delaware — claimed th…